Astera Labs (NASDAQ:ALAB) Stock Falls 1.4% After Analyst Downgrade

Astera Labs, Inc. (NASDAQ:ALAB) shares were down 1.4% during mid-day trading on Friday after Northland Securities downgraded the stock from an outperform rating to a market perform rating. The stock traded as low as $326.25 and last traded at $342.21. Approximately 4,059,810 shares traded hands during trading, a decline of 22% from the average daily volume of 5,191,552 shares. The stock had previously closed at $347.05.

Other equities research analysts have also issued research reports about the stock. Weiss Ratings reiterated a “hold (c)” rating on shares of Astera Labs in a research note on Tuesday, August 18th. Needham & Company LLC increased their price target on Astera Labs from $260.00 to $425.00 and gave the stock a “buy” rating in a research report on Wednesday, August 5th. TD Cowen cut their price target on Astera Labs from $425.00 to $375.00 and set a “hold” rating on the stock in a report on Wednesday, August 5th. Susquehanna upped their price objective on Astera Labs from $230.00 to $275.00 and gave the stock a “neutral” rating in a research note on Friday, July 31st. Finally, Royal Bank Of Canada increased their target price on Astera Labs from $425.00 to $500.00 and gave the stock an “outperform” rating in a research report on Wednesday, August 5th. Ten analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $348.33.

Insider Buying and Selling

In other news, Director Stefan Dyckerhoff sold 8,994 shares of the firm’s stock in a transaction on Wednesday, September 2nd. The stock was sold at an average price of $274.96, for a total transaction of $2,472,990.24. Following the transaction, the director directly owned 3,309 shares of the company’s stock, valued at approximately $909,842.64. This trade represents a 73.10% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, General Counsel Philip Mazzara sold 6,801 shares of the company’s stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $340.50, for a total transaction of $2,315,740.50. Following the completion of the sale, the general counsel directly owned 96,542 shares of the company’s stock, valued at $32,872,551. The trade was a 6.58% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last 90 days, insiders have sold 396,059 shares of company stock valued at $122,605,660. Company insiders own 10.40% of the company’s stock.

Trending Headlines about Astera Labs

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Astera Labs introduced Aries 7, which it describes as the industry’s first PCIe 7 signal-conditioning portfolio spanning copper and optical interconnects. The product family includes retimers, redrivers, cable modules, optical drivers and optical transimpedance amplifiers designed for AI infrastructure. The launch expands ALAB’s addressable market and strengthens its positioning in high-speed connectivity for AI systems. Astera Labs Announces Aries 7
• Positive Sentiment: Analysts view Aries 7 as part of Astera Labs’ broader push to benefit from surging AI connectivity demand. The portfolio could help ALAB compete more directly with Marvell Technology and Credo Technology, while its optical products may give the company additional exposure to next-generation AI data-center architectures. ALAB Expands PCIe Portfolio With Aries 7
• Neutral Sentiment: Marvell’s projection that connecting AI chips could become a $37 billion business supported the broader AI-connectivity investment theme and highlighted potential demand for companies such as ALAB. However, the coverage also noted Astera Labs’ reliance on a limited number of major customers and its elevated valuation, increasing execution risk. Marvell Says Connecting AI Chips Could Be a $37 Billion Business
• Negative Sentiment: Northland Securities downgraded ALAB from “outperform” to “market perform,” signaling reduced near-term upside after the stock’s substantial rally.
• Negative Sentiment: Jim Cramer said he likes Astera Labs’ business but believes the shares are too expensive. That warning reinforces valuation concerns, with the stock trading at a very high earnings multiple despite strong growth expectations. Jim Cramer Likes This Stock but Has a Problem With the Price

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the stock. Keating Financial Advisory Services Inc. acquired a new stake in Astera Labs in the second quarter worth approximately $25,000. Archer Investment Corp bought a new position in Astera Labs during the 2nd quarter valued at $30,000. Transamerica Financial Advisors LLC acquired a new position in shares of Astera Labs during the 2nd quarter valued at $35,000. Continuum Advisory LLC acquired a new position in shares of Astera Labs during the 2nd quarter valued at $37,000. Finally, Johnson Financial Group Inc. bought a new stake in shares of Astera Labs in the 2nd quarter worth $43,000. 60.47% of the stock is currently owned by institutional investors.

Astera Labs Stock Performance

The company has a market cap of $59.37 billion, a P/E ratio of 169.41 and a beta of 3.68. The stock has a 50 day moving average price of $316.82 and a 200 day moving average price of $290.03.

Astera Labs (NASDAQ:ALAB) last announced its earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, beating the consensus estimate of $0.69 by $0.11. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The business had revenue of $392.40 million during the quarter, compared to analysts’ expectations of $360.85 million. During the same quarter last year, the business posted $0.44 earnings per share. The company’s quarterly revenue was up 104.5% on a year-over-year basis. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, equities research analysts predict that Astera Labs, Inc. will post 2.7 earnings per share for the current year.

Astera Labs Company Profile

Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help data centers connect and manage processors, memory, storage, and networking components in high-performance computing systems.

The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) smart memory controllers, Scorpio PCIe switches, Taurus Ethernet fabric switches, and Leo CXL memory connectivity products.